학술논문

Long-term outcomes of innovator versus generic melphalan formulation in autologous hematopoietic cell transplantation for multiple myeloma
Document Type
Article
Source
In Hematology/Oncology and Stem Cell Therapy June 2021 14(2):114-118
Subject
Language
ISSN
1658-3876